Tomoya Horiguchi

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection

Masato Inaba, Yuki Higashimoto, Yoko Toyama et al. · International Journal of Infectious Diseases · 2021 · 79 citations · Full text

Risk Factors of Infectious Complications After Endobronchial Ultrasound-Guided Transbronchial Biopsy

Tomohide Souma, Tomoyuki Minezawa, Hiroshi Yatsuya et al. · CHEST Journal · 2020 · 28 citations · Full text

Fatal disseminated mucormycosis associated with <scp>COVID</scp>‐19

Tomoya Horiguchi, Tetsuya Tsukamoto, Yoko Toyama et al. · Respirology Case Reports · 2022 · 13 citations · Full text

Immunology, Severe Covid-19, Pathology +8

Clinical features of primary lung cancer presenting as pulmonary consolidation mimicking pneumonia

Sayako Morikawa, Takuya Okamura, Teppei Yamaguchi et al. · SHILAP Revista de lepidopterología · 2016 · 12 citations · Full text